This site uses cookies to ensure the best viewing experience for our readers.
Israeli digital health VC OTV raises new $170 million fund

Israeli digital health VC OTV raises new $170 million fund

"The Covid-19 pandemic elucidated the importance of digital products to the global healthcare ecosystem," said OTV General Partner Alejandro Weinstein

Meir Orbach | 14:01  03.12.2020
Israeli venture capital fund OTV (formerly Olive Tree Ventures) has raised a new fund of $170 million, a source told Calcalist under the condition of anonymity. The fund, whose primary focus is digital health, raised most of the money from institutional investors and private investors. OTV’s portfolio includes TytoCare, which raised $50 million, Lemonaid Health, which has raised $30 million, Emedgene, and others.

“OTV’s goal for the upcoming period is to harness our expertise in facilitating the growth of digital health companies, and identify the market leaders of tomorrow,” said Alejandro Weinstein, General Partner, OTV. “Digital health technology is increasingly important for strained healthcare systems seeking to provide accessible and affordable treatment, especially to traditionally under-served populations. The Covid-19 pandemic elucidated the importance of digital products to the global healthcare ecosystem, but industry pain points predated the current crisis and clear solutions will be needed in the years to come.”

OTV co-founder Amir Lahat. Photo: Amit Shaal OTV co-founder Amir Lahat. Photo: Amit Shaal OTV co-founder Amir Lahat. Photo: Amit Shaal

OTV was founded in 2015 by General Partners Mayer Gniwisch, Amir Lahat, and Alejandro Weinstein. OTV also announced the appointment of Jose Antonio Urrutia Rivas as Head of Asia Pacific. He will manage OTV’s new Asia Pacific office, based in China. The new office will complement existing branches in New York, Tel Aviv and Montreal. In 2019, OTV purchased Israeli company META, which had previously raised significant funds, with the goal of resuscitating it.
share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS